The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...
WASHINGTON, Jan. 20, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in clinical trials, formally recognizing ...
One of the main obstacles to the routine implementation of Bayesian methods has been the absence of efficient algorithms for carrying out the computational tasks implicit in the Bayesian approach. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results